Kolon Tissue Gene, Inc reported raising $29.6 Million in an initial SEC Form D filing, from an offering of $29.6 Million
Round Type
Venture
RockvilleBiotechnologyQuick answer
Kolon TissueGene, Inc. raised $29.6 Million in a funding round, dated August 26, 2022. Kolon TissueGene, Inc. is based in Rockville, Maryland, United States.
- How much did Kolon TissueGene, Inc. raise?
- Kolon TissueGene, Inc. raised $29.6 Million in a funding round on August 26, 2022.
- What does Kolon TissueGene, Inc. do?
- At Kolon TissueGene, our mission is to provide safe and effective therapies to patients by reducing pain and improving function associated with various orthopedic diseases and degenerative disorders.
- Where is Kolon TissueGene, Inc. based and how big is it?
- Kolon TissueGene, Inc. is based in Rockville, Maryland, United States.
- Who are the decision-makers at Kolon TissueGene, Inc?
- Fundz holds 1 contact at Kolon TissueGene, Inc., including the Executive Officer, Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Kolon TissueGene, Inc. that raised within 45 days of this round, from Fundz verified event records.
- NXPharmagen raised $590K (Seed) on October 10, 2022.
- Scene Health raised $2.1M on October 10, 2022.
- Immunic raised $60M on October 10, 2022.
- Immunic Therapeutics raised $60M (Post-IPO Equity) on October 10, 2022.
- Clerkenwell Health raised $2.3M (Seed) on October 10, 2022.
- Earth Science Tech raised $1.2M (Seed) on October 8, 2022.
Who to call at Kolon TissueGene, Inc., and when
A new round usually means Kolon TissueGene, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Kolon TissueGene, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Kolon TissueGene, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Kolon TissueGene, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Kolon TissueGene, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Kolon TissueGene, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.